Quantbot Technologies LP Supernus Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

  • $3.24 Billion
  • Q3 2025

A detailed history of Quantbot Technologies LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 3,349 shares of SUPN stock, worth $150,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,349
Previous 18,566 81.96%
Holding current value
$150,705
Previous $585,000 72.65%
% of portfolio
0.0%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$31.45 - $47.79 $478,574 - $727,220
-15,217 Reduced 81.96%
3,349 $160,000
Q2 2025

Aug 13, 2025
BUY
$30.29 - $33.43 $466,950 - $515,356
15,416 Added 489.4%
18,566 $585,000
Q1 2025

May 13, 2025
BUY
$31.17 - $40.0 $98,185 - $126,000
3,150 New
3,150 $103,000
Q3 2024

Nov 13, 2024
SELL
$25.77 - $35.16 $556,657 - $759,491
-21,601 Reduced 95.47%
1,026 $31,000
Q2 2024

Aug 09, 2024
BUY
$25.99 - $33.85 $588,075 - $765,923
22,627 New
22,627 $605,000
Q4 2023

Feb 14, 2024
BUY
$22.72 - $29.68 $152,246 - $198,885
6,701 New
6,701 $193,000
Q2 2023

Aug 08, 2023
BUY
$29.91 - $38.73 $99,630 - $129,009
3,331 New
3,331 $100,000
Q4 2022

Feb 13, 2023
SELL
$31.09 - $37.88 $36,002 - $43,865
-1,158 Reduced 68.56%
531 $18,000
Q3 2022

Nov 07, 2022
BUY
$28.79 - $35.41 $48,626 - $59,807
1,689 New
1,689 $57,000
Q4 2021

Feb 11, 2022
SELL
$26.37 - $34.22 $163,045 - $211,582
-6,183 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$23.54 - $31.39 $145,547 - $194,084
6,183 New
6,183 $164,000
Q2 2021

Aug 12, 2021
SELL
$26.72 - $33.19 $46,252 - $57,451
-1,731 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$24.15 - $31.45 $41,803 - $54,439
1,731 New
1,731 $45,000
Q2 2019

Aug 13, 2019
SELL
$29.96 - $38.87 $166,637 - $216,194
-5,562 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$32.77 - $41.99 $4,522 - $5,794
-138 Reduced 2.42%
5,562 $194,000
Q4 2018

Feb 13, 2019
BUY
$30.84 - $49.51 $106,336 - $170,710
3,448 Added 153.11%
5,700 $189,000
Q3 2018

Nov 13, 2018
BUY
$42.7 - $56.55 $96,160 - $127,350
2,252 New
2,252 $113,000
Q2 2018

Aug 13, 2018
SELL
$44.1 - $59.85 $97,549 - $132,388
-2,212 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$37.15 - $46.9 $192,474 - $242,988
-5,181 Reduced 70.08%
2,212 $101,000
Q4 2017

Feb 12, 2018
BUY
$36.4 - $42.6 $43,134 - $50,481
1,185 Added 19.09%
7,393 $294,000
Q3 2017

Nov 07, 2017
BUY
$36.75 - $49.65 $228,144 - $308,227
6,208
6,208 $248,000

Others Institutions Holding SUPN

# of Institutions
330
Shares Held
60.2M
Call Options Held
234K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email